{"id":"W4308949853","doi":"10.1038/s41573-022-00582-5","title":"Beyond PI3Ks: targeting phosphoinositide kinases in disease","year":2022,"lang":"en","type":"review","venue":"Nature Reviews Drug Discovery","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Cancer Research Society; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Michael Smith Health Research BC; National Cancer Institute; National Science Foundation","keywords":"Phosphoinositide 3-kinase; Kinase; Disease; Medicine; Biology; Cancer research; Signal transduction; Cell biology; PI3K/AKT/mTOR pathway; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002414972,0.001244241,0.005727476,0.0007454126,0.0001862315,0.0001684037,0.001000354,0.0006485445,0.001391407],"category_scores_gemma":[0.004073565,0.000913306,0.002574246,0.002175599,0.0001762938,0.0004610181,0.0009713273,0.005835122,0.0003385977],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02725889,"about_ca_system_score_gemma":0.02066706,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002184527,"about_ca_topic_score_gemma":0.00003834851,"domain_scores_codex":[0.991957,0.001257138,0.002217587,0.001716018,0.001625882,0.001226347],"domain_scores_gemma":[0.995171,0.001385195,0.0008582677,0.001896068,0.00005894165,0.0006305478],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001234242,0.0004311686,0.00002218011,0.1728276,0.0001954784,0.004369425,0.0001022512,0.000002059084,2.727495e-7,0.0003408463,0.06441926,0.7571661],"study_design_scores_gemma":[0.002045826,0.00003750883,0.000003672189,0.05798575,0.001594581,0.0002261932,0.00004425356,0.00001524085,0.000001150411,0.00005791592,0.9372263,0.0007616292],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004703293,0.9900309,0.000001279603,0.0001328885,0.0009197943,0.005784293,0.0002958885,0.00008319603,0.002704771],"genre_scores_gemma":[0.00002253364,0.9869416,0.0001168528,0.0009450843,0.0009946779,0.001786909,0.003068383,0.0002611479,0.00586276],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.872807,"threshold_uncertainty_score":0.9995214,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03358830935975977,"score_gpt":0.3736598770361418,"score_spread":0.3400715676763821,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}